Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

Last updated: April 14, 2025
Sponsor: Boston Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Osteomyelitis

Opioid Use Disorder

Joint Injuries

Treatment

Unrelated videos

RETAIN

Clinical Study ID

NCT06489535
H-44905
K23DA054363
  • Ages 18-65
  • All Genders

Study Summary

This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy.

Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs.

The study objectives are to:

  • Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD.

  • Establish preliminary estimates of intervention efficacy.

  • Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials.

Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Between 18 and 65 years of age

  • Able to provide Informed Consent

  • Admitted to Boston Medical Center on any inpatient unit for an active seriousinjection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia,septic arthritis, epidural abscess or other serious infection in which two weeks ormore of antibiotics are recommended

Exclusion

Exclusion Criteria:

  • Not able to give informed consent

  • Cognitive ability (defined through Research Assistant (RA) determination)

  • Inability to complete assessments in English or Spanish (defined through RAdetermination).

  • Exclusion for any reason under PI discretion

  • Unable to provide names and contact information for at least two verifiable locatorpersons who will know where to find them in the future.

  • In police custody or expecting incarceration

Study Design

Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Unrelated videos
Phase:
Study Start date:
January 06, 2025
Estimated Completion Date:
March 31, 2026

Connect with a study center

  • Boston Medical Center

    Boston, Massachusetts 02118
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.